AMP-activated protein kinase activation is cytotoxic to various cancer cell types, and inhibits tumour growth (Buzzai et al, 2007; Zakikhani et al, 2008), supporting AMPK as a tumour suppressor and a potential target for cancer therapy and chemoprevention (Fay et al, 2009). Here, PRKAA2 is linked to neoplasm.